Publication Name	World Journal of Gastroenterology
Manuscript ID	54577
Country	Denmark

Received	2020-02-07 16:39
Peer-Review Started	2020-02-07 16:39
First Decision by Editorial Office Director	2020-02-27 02:17
Return for Revision	2020-02-27 02:17
Revised	2020-03-05 12:44
Publication Fee Transferred
Second Decision by Editor	2020-04-17 08:41
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director	2020-04-17 17:57
Articles in Press	2020-04-17 17:57
Edit the Manuscript by Language Editor
Typeset the Manuscript	2020-04-27 05:52
Publish the Manuscript Online	2020-04-28 08:04

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Case Report
Article Title	Severe steroid refractory gastritis induced by Nivolumab: A case report
Manuscript Source	Unsolicited Manuscript
All Author List	Helene Hjorth Vindum, Jørgen S Agnholt, Anders Winther Moelby Nielsen, Mette Bak Nielsen and Henrik Schmidt
ORCID	Author(s) ORCID Number Helene Hjorth Vindum http://orcid.org/0000-0002-8242-9702 Jørgen S Agnholt http://orcid.org/0000-0003-2822-6442 Anders Winther Moelby Nielsen http://orcid.org/0000-0003-2843-2879 Mette Bak Nielsen http://orcid.org/0000-0001-8974-6869 Henrik Schmidt http://orcid.org/0000-0002-4063-3561
Funding Agency and Grant Number
Corresponding Author	Helene Hjorth Vindum, MD, Department of Oncology, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, Aarhus 8200, Denmark. helra9@rm.dk
Key Words	Gastritis; Immune checkpoint inhibitors; Nivolumab; Case report; Immune-related adverse events; Infliximab
Core Tip	Lower gastrointestinal side effects, such as diarrhea and colitis, caused by immune checkpoint inhibitors are well described, but upper gastrointestinal side effects are less frequently reported. Here, we present a case of severe corticosteroid refractory gastritis induced by Nivolumab. The patient’s symptoms resolved after administration of Infliximab. The treatment was in line with current guidelines for treatment of gastritis.
Publish Date	2020-04-28 08:04
Citation	Vindum HH, Agnholt JS, Nielsen AWM, Nielsen MB, Schmidt H. Severe steroid refractory gastritis induced by Nivolumab: A case report . World J Gastroenterol 2020; 26(16): 1971-1978
URL	https://www.wjgnet.com/1007-9327/full/v26/i16/1971.htm
DOI	https://dx.doi.org/10.3748/wjg.v26.i16.1971

Full Article (PDF)	WJG-26-1971.pdf
Full Article (Word)	WJG-26-1971.docx
CARE Checklist–2016	54577-CARE-Checklist–2016-revision.pdf
Manuscript File	54577-Review.docx
Answering Reviewers	54577-Answering reviewers.pdf
Audio Core Tip	54577-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	54577-Conflict-of-interest statement.pdf
Copyright License Agreement	54577-Copyright license agreement.pdf
Signed Informed Consent Form(s) or Document(s)	54577-Informed consent statement.pdf
Non-Native Speakers of English Editing Certificate	54577-Language certificate.pdf
Peer-review Report	54577-Peer-review(s).pdf
Scientific Misconduct Check	54577-Scientific misconduct check.pdf
Scientific Editor Work List	54577-Scientific editor work list.pdf
CrossCheck Report	54577-CrossCheck report.pdf